Risk factors for breast cancer.
暂无分享,去创建一个
[1] A. LaCroix,et al. Bone mineral density and breast cancer risk in postmenopausal women. , 2001, Journal of clinical epidemiology.
[2] D E Goldgar,et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. , 1997, American journal of human genetics.
[3] G. Berglund,et al. Smoking associated with hormone receptor negative breast cancer , 2001, International journal of cancer.
[4] T. Sarkola,et al. Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women. , 1999, Alcoholism, clinical and experimental research.
[5] T. Sellers,et al. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. , 1999, JAMA.
[6] D J Schaid,et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. , 1999, The New England journal of medicine.
[7] A. Mes-Masson,et al. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. , 1998, American journal of human genetics.
[8] Ross,et al. RESPONSE: re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin , 2000, Journal of the National Cancer Institute.
[9] A. Chetrit,et al. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. , 1999, Fertility and sterility.
[10] J. Ranstam,et al. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] P. Newcomb,et al. A record-based evaluation of induced abortion and breast cancer risk (United States) , 2000, Cancer Causes & Control.
[12] S. Gardner,et al. New Recommendations from the 1999 American College of Cardiology/American Heart Association Acute Myocardial Infarction Guidelines , 2001, The Annals of pharmacotherapy.
[13] F. Berrino,et al. Alcohol consumption and total estradiol in premenopausal women. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] J. Struewing,et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutation , 1998, The Lancet.
[15] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[16] K Offit,et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. , 1997, JAMA.
[17] D. Torgerson,et al. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. , 2001, JAMA.
[18] J. Fraumeni,et al. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.
[19] Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. , 2000 .
[20] S. Thacker,et al. A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer , 1991 .
[21] D. Bentley,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.
[22] Postmenopausal hormone therapy and mortality. , 1997 .
[23] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .
[24] H. Adami,et al. Transient increase in the risk of breast cancer after giving birth. , 1994, The New England journal of medicine.
[25] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[26] E. Vittinghoff,et al. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. , 2000, Journal of the American Medical Association (JAMA).
[27] N. Cook,et al. Physical activity and breast cancer risk: the Women's Health Study (United States) , 2001, Cancer Causes & Control.
[28] E. Lower,et al. The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer , 1999, Breast Cancer Research and Treatment.
[29] J. Thalabard,et al. Breastfeeding and risk of breast cancer: a metaanalysis of published studies. , 2000, Human reproduction update.
[30] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[31] P. Boyle,et al. Lactation and breast cancer risk: a case–control study in Connecticut , 2001, British Journal of Cancer.
[32] C. Matthews,et al. Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study , 2001, British Journal of Cancer.
[33] D. Reboussin,et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. , 2000, The New England journal of medicine.
[35] E. Mariman,et al. Localization of the gene for Cowden disease to chromosome 10q22–23 , 1996, Nature Genetics.
[36] Anthony Gamst,et al. Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .
[37] C. Amos,et al. Fine mapping of a genetic locus for Peutz-Jeghers syndrome on chromosome 19p. , 1997, Cancer research.
[38] O. Olopade,et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2 , 1999, The Lancet.
[39] D. Drachman,et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. , 2001, Archives of neurology.
[40] F. Speizer,et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. , 1998, JAMA.
[41] P. Tonin,et al. The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. , 1996, American journal of human genetics.
[42] K. Heimdal,et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study , 2000, The Lancet.
[43] S. Shapiro,et al. Induced and spontaneous abortion in relation to risk of breast cancer (United States) , 1997, Cancer Causes & Control.
[44] W. Dupont,et al. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[45] P. Porter,et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. , 2000, Journal of the National Cancer Institute.
[46] K M Kuntz,et al. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. , 1997, The New England journal of medicine.
[47] P. Schlag,et al. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families , 1997, Oncogene.
[48] J. Klijn,et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 , 1998, The Lancet.
[49] F. Couch,et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.
[50] T. Lash,et al. Alcohol Drinking and Risk of Breast Cancer , 2000, The breast journal.
[51] J. Kaprio,et al. Stress of daily activities and risk of breast cancer: A prospective cohort study in Finland , 2001, International journal of cancer.
[52] W. Willett,et al. Fracture history and risk of breast and endometrial cancer. , 2001, American journal of epidemiology.
[53] C. la Vecchia,et al. Fertility treatment and risk of breast cancer. , 1996, Human reproduction.
[54] E D Brown,et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. , 2001, Journal of the National Cancer Institute.
[55] S. Cummings,et al. Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). , 2001, The American journal of medicine.
[56] C. Lowe,et al. Age at first birth and breast cancer risk. , 1970, Bulletin of the World Health Organization.
[57] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[58] J. Olsen,et al. Induced abortion and the risk of breast cancer. , 1997, The New England journal of medicine.
[59] B. Weber,et al. Assessing the risk of breast cancer. , 2000, The New England journal of medicine.
[60] M. Thun,et al. Tubal sterilization and risk of breast cancer mortality in US women , 2001, Cancer Causes & Control.
[61] J. Eyfjörd,et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. , 1997, American journal of human genetics.
[62] K Offit,et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. , 1997, JAMA.
[63] Taylor Murray,et al. Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.
[64] G M Lenoir,et al. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage , 1996, Cancer.
[65] S. Self,et al. Risk of breast cancer in a cohort of infertile women. , 1996, Gynecologic oncology.
[66] D. Grabrick,et al. Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[67] E. Nabel. Coronary heart disease in women--an ounce of prevention. , 2000, The New England journal of medicine.
[68] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[69] W. Zheng,et al. Abortion history and breast cancer risk: Results from the Shanghai breast cancer study , 2001, International journal of cancer.
[70] M. Melbye,et al. Age at Any Birth Is Associated with Breast Cancer Risk , 2001, Epidemiology.
[71] A. Venn,et al. Breast and ovarian cancer incidence after infertility and in vitro fertilisation , 1995, The Lancet.
[72] B. Macmahon. Reproduction and cancer of the breast , 1993 .
[73] E. Negri,et al. Hysterectomy, Oophorectomy in Premenopause, and Risk of Breast Cancer , 1997, Obstetrics and gynecology.
[74] L. Cupples,et al. Alcohol consumption and risk of breast cancer: the Framingham Study revisited. , 1999, American journal of epidemiology.
[75] Julian Peto,et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.
[76] Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. , 2000 .
[77] M. Skolnick,et al. Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .
[78] S Hulley,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[79] S. Haslam,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Hormone Replacement Therapy with Estrogen or Estrogen plus Medroxyprogesterone Acetate Is Associated with Increased Epithelial Proliferation , 2022 .
[80] D. Page,et al. Relation between component parts of fibrocystic disease complex and breast cancer. , 1978, Journal of the National Cancer Institute.
[81] J L Kelsey,et al. Reproductive factors and breast cancer. , 1993, Epidemiologic reviews.
[82] N. Risch,et al. Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994 .
[83] R. Ross,et al. RESPONSE: re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin , 2000, Journal of the National Cancer Institute.
[84] M. Longnecker,et al. Age at any full-term pregnancy and breast cancer risk. , 2000, American journal of epidemiology.
[85] S. Love,et al. Fibrocystic Disease of the Breast — A Nondisease? , 1982 .
[86] O. Olopade,et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. , 1999, Journal of the National Cancer Institute.
[87] G A Colditz,et al. A prospective study of folate intake and the risk of breast cancer. , 1999, JAMA.
[88] G. Colditz,et al. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. , 2000, American journal of epidemiology.